Alkem Laboratories Ltd

NSE: ALKEM · BSE: 539523 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹5,274.00
Market cap: ₹63,059 Cr
Revenue (annual): ₹14,712 Cr
Net profit (annual): ₹2,302 Cr
P/E (TTM): 29.2×Sector 50.4×
Promoter holding: 49.70%-1.50% QoQ
FII holding: 10.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Product Launch 2 Management Change 2 Earnings Call 2 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Aug 2026 18:00 IST BSE

Earnings Call

Alkem Laboratories Investor Presentation: Key Takeaways

Alkem reported Q1FY27 revenue of INR 3,740cr, up 11% YoY. India sales grew 10.3%, while International jumped 16%. EBITDA margin stood at 20.5%. Net profit declined 21.7% due to taxation.

Call: Guides 12% growth

Open call summary → Read the filing ↗

1 Jun 2026 16:27 IST BSE

Earnings Call

Alkem Laboratories Earnings Call: Key Takeaways

Alkem reported strong FY26 results with landmark INR 3,000cr+ EBITDA. Strategy focuses on chronic therapy growth in India and international expansion, particularly with the semaglutide launch.

Open call summary → Read the filing ↗